ETFMG Treatments Testing and Advancements ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch GERM and buy or sell other stocks, ETFs, and their options commission-free!

About GERM

GERM tracks a tier-weighted index of US-listed healthcare companies engaged in treatments, testing, and other medical advancements. Holdings are selected by the index committee. 

GERM Key Statistics

AUM
AUM
Price-Earnings ratio
Price-Earnings ratio
30-Day yield
30-Day yield
Average volume
1.68K
Average volume1.68K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$20.20
52 Week high$20.20
52 Week low
$15.67
52 Week low$15.67
Expense ratio
Expense ratio

Stock Snapshot

ETFMG Treatments Testing and Advancements ETF(GERM) stock is priced at $18.57, giving the company a market capitalization of 9.29M.

ETFMG Treatments Testing and Advancements ETF(GERM) stock opened on 2026-02-13 at —. The price climbed to — and dipped to —.

The ETFMG Treatments Testing and Advancements ETF(GERM)'s current trading volume is 0, compared to an average daily volume of 1.68K.

During the past year, ETFMG Treatments Testing and Advancements ETF(GERM) stock moved between $15.67 at its lowest and $20.20 at its peak.

During the past year, ETFMG Treatments Testing and Advancements ETF(GERM) stock moved between $15.67 at its lowest and $20.20 at its peak.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.